Compare BHB & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHB | BWAY |
|---|---|---|
| Founded | 1887 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 527.8M | 450.8M |
| IPO Year | 1995 | N/A |
| Metric | BHB | BWAY |
|---|---|---|
| Price | $34.98 | $14.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $36.67 | $13.25 |
| AVG Volume (30 Days) | 153.0K | ★ 169.5K |
| Earning Date | 04-21-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.31 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $22.68 | $309.69 |
| Revenue Next Year | $3.66 | $26.21 |
| P/E Ratio | ★ $15.14 | $81.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.50 | $7.84 |
| 52 Week High | $36.05 | $26.63 |
| Indicator | BHB | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 69.58 | 51.40 |
| Support Level | $28.43 | $14.56 |
| Resistance Level | $35.74 | $16.63 |
| Average True Range (ATR) | 0.73 | 0.72 |
| MACD | 0.35 | 0.48 |
| Stochastic Oscillator | 89.71 | 92.73 |
Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.